Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers
PaperCitations, authors & open-access status
Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 172 citations, 2020 year and bronze oa status.
172
Citations
2020
Year
bronze
OA Status